Fei Xiong

3.6k citations
110 papers · 2.9k indexed · 1 hit paper · h-index 29
Topics
Nanoparticle-Based Drug Delivery (40 papers)Nanoplatforms for cancer theranostics (18 papers)RNA Interference and Gene Delivery (11 papers)

In The Last Decade

Fei Xiong

105 papers receiving 2.8k citations

Hit Papers

The Smart Drug Delivery System and Its Clinical Potential20162026201920222016250500750

Peers

Fei Xiong
Comparison fields: 5 of 131
  • Biomaterials 1.1k
  • Biomedical Engineering 1.0k
  • Molecular Biology 988
  • Materials Chemistry 551
  • Oncology 243
Replace Sanjun Shi with:
Sanjun Shi China
Tongkai Chen China
Saman Sargazi Iran
Meiwan Chen Macao
Xiaoye Yang China
Faisal Raza China
Fei Xiong relative to Sanjun Shi China Sanjun Shi's profile →
Citations per field
00.5×1.5×1.8×
Sanjun Shi · 1×
Citations per year

Countries citing papers authored by Fei Xiong

Since Specialization
Citations

This map shows the geographic impact of Fei Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Xiong more than expected).

Fields of papers citing papers by Fei Xiong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Xiong. The network helps show where Fei Xiong may publish in the future.

Co-authorship network of co-authors of Fei Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Xiong. A scholar is included among the top collaborators of Fei Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Xiong. Fei Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 2
4 5
5 4
6 16
7 5
8 1
9 16
10 29
11 50
12 3
13 89
14 34
15 28
16 7
17
[2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice].
1
18 70
19 21
20 8

About Fei Xiong

Fei Xiong is a scholar working on Biomaterials, Pharmaceutical Science and Hematology, having authored 110 papers that have together received 2.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (40 papers), Nanoplatforms for cancer theranostics (18 papers) and RNA Interference and Gene Delivery (11 papers). The work is most often cited by research in Biomaterials (1.1k citations), Pharmaceutical Science (225 citations) and Molecular Medicine (133 citations). Fei Xiong has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Ning Gu, Fang Yang, Dong Liu, Hao Wang, Yu Zhang, Wen‐Cai Ye, Liang Ge, Shengxin Huang, Zhu Jia‐bi and Xiaolong Hu. Their work appears in journals such as Advanced Materials, Nano Letters and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026